Veracyte, Inc.
VCYT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3 | $2 | $2 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $2 | $2 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 1.3% | 13.7% | -3.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 67.8% | 69% | 69.5% | 66.4% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 18.3% | 5.2% | 5.7% | 8.2% |
| Net Income | $0 | -$0 | $0 | $0 |
| % Margin | 14.5% | -0.8% | 6.2% | 4.3% |
| EPS Diluted | 0.24 | -0.013 | 0.088 | 0.06 |
| % Growth | 2,020.8% | -114.2% | 46.7% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |